Molecular Diagnostics
Genetic Screening Can Identify Men at Higher Risk of Aggressive Prostate Cancer
Genetic mutations have been identified that facilitate screening of men for prostate cancer, particularly men with a family history of the disease, to identify those who are at higher risk of aggressive forms and in need of lifelong monitoring. More...03 Mar 2014
DNA Reference Samples Will Regularize Diagnosis of Rett Syndrome
A panel of highly characterized DNA samples that identify mutations in the gene that encodes methyl CpG binding protein 2 are now available to clinical laboratories as reference material for the diagnosis of Rett syndrome. More...26 Feb 2014
Gold Member
Collection and Transport System
PurSafe Plus®
Capillary Blood Collection Tube
IMPROMINI M3
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
In Other News
Dako and Amgen Collaborate to Develop New Diagnostic Test
Superior Single-Cell Library Preparation Technology Now Available for Additional Platforms
New Genetic Forms of Neurodegeneration Discovered
New Tool Developed to Identify Genetic Risk Factors
Dedicated Blood DNA Collection Tube Receives European Marketing Approval
Next-Generation Breast Cancer Tests Provide More Precise Prognosis
Fetal Hypoxia Determined by mRNAs Abundance in Maternal Blood
DNA Health Monitoring Campaign Launched
Prognostic Test Predicts Prostate Cancer-Specific Death and Metastases
Germline and Somatic Variants Analyzed in Ovarian Cancer
Molecular Blood Test Detects Lung Cancer
Clinical Performance Supports New Diagnostic Assay for Multiple Sclerosis
DNA-Barcode Profiling Identifies Cancer Biomarkers in Fine Needle Aspirates
Transformative New System Brings Whole Genome Sequencing to the Desktop
Novel Subtyping Assay Detects Clostridium Virulence Genes
Amgen and Illumina Collaborate on Oncology Companion Diagnostic Test
DNA-Enrichment Technology May Help Replace Biopsies for Cancer Mutation Testing
Response of Early Stage Breast Cancer to Chemotherapy Predicted
New System Breaks Technology and Cost Barriers for High-Throughput Large-Genome Sequencing
Cancer Origin Test Covered by Large Private Health Insurer
Genetic Mutation Appears to Drive Rare Brain Cancer
Biomarker Improves Diagnosis of Esophageal Cancer
Biopsy Test Predicts Aggressive form of Skin Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.